Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Peptide Vaccine
Imiquimod
Locations
5
Germany
Katharinenhospital
Stuttgart, Baden-Wurttemberg, Germany
Diakonie-Klinikum Stuttagrt
Stuttgart, Baden-Wurttemberg, Germany
Marienhospital
Stuttgart, Baden-Wurttemberg, Germany
Robert-Bosch-Krankenhaus Abteilung fuer Haematologie, Onkologie und Palliativmedizin
Stuttgart, Baden-Wurttemberg, Germany
University Hospital Tuebingen
Tübingen, Baden-Wurttemberg, Germany
Start Date
October 5, 2016
Primary Completion Date
September 30, 2022
Completion Date
November 18, 2022
Last Updated
November 28, 2022
Lead Sponsor
University Hospital Tuebingen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions